If a product page provides no verifiable pharmacy information or state licensing details, treat that as a material warning sign
Am J Cancer Res 11:23692385 Castao M, Toms-Prez S, Gonzlez-Cant E, Aghababyan C, Mascars-Martnez A, Santonja N, Herreros-Pomares A, Oto J, Medina P, Gtte M et al (2023) Neutrophil extracellular traps and cancer: trapping our attention with their involvement in ovarian Cancer
Clinical studies are ongoing globally, and Anifrolumab is under regulatory review in the EU and Japan (132)
Yet the deeper story of GHK-Cuits influence on gene expression, tissue remodeling, and regenerative signalingsuggests that we may only be beginning to understand the full potential of this small but biologically powerful peptide